MedTrace Logo

Analysis of the Role of IgE Proteoforms in Health and Disease

NCT07328178 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-01-09

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the role of IgE proteoforms in healthy volunteers and in patients with type I allergy, patients with chronic spontaneous urticaria, patients with a recent history of anaphylaxis, patients with mastocytosis, patients with hereditary alpha tryptasemia, patients with X-linked agammaglobulinemia (XLA), and patients undergoing desensitization for venom or medication allergy.

Conditions

  • Anaphylaxis
  • Mastocytosis
  • X-linked Agammaglobulinaemia
  • Venom Allergy
  • Chronic Spontaneous Urticaria (CSU)
  • Type I Allergy
  • Medication Allergy
  • Healthy Control
  • Hereditary Alpha-Tryptasemia

Interventions

OTHER

Blood sample collection

Blood sample collection

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Rik Schrijvers, MD, PhD · UZ/KU Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2029-01-01
Completion
2029-01-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07328178 on ClinicalTrials.gov